Blood test for early detection of uterine cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is testing a simple blood test to find signs of uterine (endometrial) cancer early. If you have been diagnosed with uterine cancer or a precancerous condition, or if you are healthy, you may be able to join and help improve how we screen for this cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and at least 18 years old.
- You are either a patient with endometrial cancer, a patient with atypical hyperplasia (a precancerous condition), or a healthy woman with no cancer or suspicious findings.
- If you have cancer or hyperplasia, your medical records must include detailed information about your diagnosis.
- You have not had any cancer treatment (such as surgery, chemotherapy, radiation, or hormone therapy) before the blood draw.
- You are not pregnant and have no other current or past cancer except endometrial cancer.
- You do not have a fever or an active infection that needs medical treatment, and you have not had an organ or stem cell transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This study looks at how blood flow in the uterus may relate to endometrial cancer. It may help researchers understand the disease better and guide future care.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This study tests whether a blood test can find cancer returning earlier than usual scans, in people who had endometrial or cervical cancer. If you've finished or are on standard treatment, your blood may help show if the cancer comes back sooner.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.